Evidence map›Paper›PMID 39447056›Full record

ArticleThe international journal of neuropsychopharmacology2024

Behavioral and neurophysiological signatures of cognitive control in humans and rats.

Samantha R Linton, Ty Lees, Ann Iturra-Mena, Brian D Kangas, Genevieve Nowicki, Rachel Lobien, Gordana Vitaliano, Jack Bergman, William A Carlezon, Diego A Pizzagalli

Abstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samantha R LintonDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
Ty LeesDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
Ann Iturra-MenaDepartment of Child and Adolescent Psychiatry, Columbia University, New York, NY, 10032, USA.
Brian D KangasDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
Genevieve NowickiMcLean Hospital, Belmont, MA 02478, USA.
Rachel LobienMcLean Hospital, Belmont, MA 02478, USA.
Gordana VitalianoDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
Jack BergmanDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
William A CarlezonDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.
Diego A PizzagalliDepartment of Psychiatry, Harvard Medical School, Boston, MA 02215, USA.ORCID 0000-0002-7772-1143

Funding

Novel Cross-Species Neurophysiological Assays of Reward and Cognitive DomainsUH3MH109334 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2018 to 2021
$1.8M
Novel Cross-Species Neurophysiological Assays of Reward and Cognitive DomainsUH2MH109334 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2016 to 2017
$1.5M
NIMH NIH HHS UH2 MH109334NIMH NIH HHS UH3 MH109334
6 · The paper itself

Abstract

backgroundDeficits in cognitive control are implicated in numerous neuropsychiatric disorders. However, relevant pharmacological treatments are limited, likely due to weak translational validity of applicable preclinical models used. Neural indices derived from electroencephalography may prove useful in comparing and translating the effects of cognition-enhancing drugs between species. In the current study, we aimed to extend our previous cross-species results by examining if methylphenidate (MPH) modulates behavioral and neural indices of cognitive control in independent cohorts of humans and rats.

methodsWe measured continuous electroencephalography data from healthy adults (n = 25; 14 female) and Long Evans rats (n = 22; 8 female) and compared both stimulus- and response-locked event-related potentials and spectral power measures across species, and their MPH-related moderation following treatment with vehicle (placebo) or 1 of 2 doses of MPH.

resultsAcross both species, linear mixed effects modeling confirmed the expected Flanker interference effect on behavior (eg, accuracy) and response-related event-related potentials. Unexpectedly, in contrast to past work, we did not observe any task-related effects on the spectral power of rodents. Moreover, MPH generally did not modulate cognitive control of either species, although some species-specific patterns offer insight for future research.

conclusionsCollectively, these findings in independent human and rodent subjects replicate some of our previously reported behavioral and neurophysiological patterns partly consistent with the notion that similar neural mechanisms may regulate cognitive control in both species. Nonetheless, these results showcase an approach to accelerate translation using a coordinated between-species platform to evaluate pro-cognitive treatments.

Indexed as

Central Nervous System StimulantsElectroencephalographyEvoked PotentialsMethylphenidateRats, Long-EvansAdultAnimalsBehavior, AnimalCognitionExecutive FunctionFemaleHumansMaleRatsSpecies SpecificityYoung AdultCentral Nervous System StimulantsMethylphenidatecingulatecognitive controlcross-speciesdopamineelectrophysiology

Identifiers

PMID39447056
PMCPMC11549206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.